Oral Iopamidol in Multidetector Computed Tomography-Module 2
FACULTY
Greg Zobel, RT(R), (CT), RHIA, CRC, CCA, CHPS
Healthcare Consultant and Adjunct Instructor
Indianapolis, Indiana
PROVIDER STATEMENT
Provided by HMP Education, an HMP Global Company.
For questions regarding this educational activity, please call 609-371-1137 or email accreditation@hmpglobal.com.
INTENDED LEARNERS
This activity is designed for radiologists, radiology nurses, and radiology technologists.
LEARNING OBJECTIVES
After completing this activity, participants should be able to:
- Apply the experiences of single center experiences within your own practice about the effectiveness of oral iopamidol in multidetector computed tomography (MDCT)
- Discuss the patient selection criteria for use of oral Iopamidol in MDCT
- Describe the benefits and limitations of oral iopamidol vs intravenous contrast in patients undergoing MDCT
CLAIMING CREDIT
To be eligible for credit, participants must complete the online activity, a post-test assessment, and the evaluation. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.
Date of last review: March 31, 2020
Release Date: December 12, 2009
Expiration Date: May 30, 2024
Estimated time to complete: 30 minutes
There is no fee associated with this activity.
CONTINUING EDUCATION
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIANS
HMP Education designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING
This continuing nursing education activity awards .5 contact hour.
VASCULAR & INTERVENTIONAL RADIOGRAPHERS
Oral Iopamidol in Multidetector Computed Tomography-Module 1 taking place on May 30, 2022 to May 30, 2024 has been approved for 0.5 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
DISCLAIMERS
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
Clinical Reviewers
Robert S. Dieter, MD, RVT, FACC
Loyola University Medicine
Chicago, Illinois
Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA
Planning Committee
In addition to the faculty listed below, HMP Education planners and staff include Kristin Ciszeski, Samantha Conforti, Randy Robbin, and Colleen Waters.
Faculty
The faculty has reported the following:
Ms. Seaman: Speakers’ Bureau—Next Science
Dr. Dieter and Mr. Zobel have disclosed no no relevant financial relationships with any commercial interests.
ADA STATEMENT
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.
PRIVACY POLICY
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
GRIEVANCE POLICY
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Conforti, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at sconforti@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint.
COMMERCIAL SUPPORT
Supported by an educational grant from Bracco Diagnostics, Inc.